New Therapeutic Approaches to Arterial Calcification Via Inhibition of Transglutaminase and &bgr;-Catenin Signaling

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|37|5811-5820

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.37, 2014-11, pp. : 5811-5820

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signaling Mechanisms Underlying A&bgr; Toxicity: Potential Therapeutic Targets for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 355-361

Bentham Science Publishers

Access to resources Recommend Favorite

The Amyloid &bgr;-Protein Precursor and Alzheimer's Disease. Therapeutic Approaches

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-12 ,pp. : 271-283

Bentham Science Publishers

Access to resources Recommend Favorite

Transglutaminase-Mediated Activation of Nuclear Transcription Factor-&kgr;B in Cancer Cells: A New Therapeutic Opportunity

By  

Current Cancer Drug Targets, Vol. 7, Iss. 6, 2007-09 ,pp. : 559-565

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Signaling and Potential New Therapeutic Approach: Possible Outcomes of NTPDase Inhibition

By  

Current Drug Targets, Vol. 3, Iss. 3, 2002-01 ,pp. : 229-245

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of &bgr;-amyloid formation as a therapeutic strategy

By Moore C.L.   Wolfe M.S.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 135-146

Informa Healthcare

Access to resources Recommend Favorite